Builds virtual patient populations from anonymised scans so medical device makers can test heart valves, stents and similar devices across a wide range of anatomies before human trials.
Why they'll be hiring in 2027. Raised a £10m Series A in October 2026, led by PXN Ventures, and plans to grow its team from 14 to 34 people at the University of Leeds' Nexus hub.